SEARCH

SEARCH BY CITATION

References

  • Aceto M. D., Botton I., Martin R., Levitt M., Bentley H. C. and Speight P. T. (1970) Pharmacologic properties and mechanism of action of amfonelic acid. Eur. J. Pharmacol. 10, 344354.
  • Anderson B. B., Chen G., Gutman D. A. and Ewing A. G. (1998) Dopamine levels of two classes of vesicles are differentially depleted by amphetamine. Brain Res. 788, 294301.
  • Brown J. M., Hanson G. R. and Fleckenstein A. E. (2001) Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors. J. Pharmacol. Exp. Ther. 298, 11501153.
  • Carboni E., Imperato A., Perezzani L. and Di Chiara G. (1989) Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28, 653661.
  • Cass W. A., Gerhardt G. A., Mayfield R. D., Curella P. and Zahniser N. R. (1992) Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration. J. Neurochem. 59, 259266.
  • Chadchankar H., Ihalainen J., Tanila H. and Yavich L. (2012) Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an alpha-synuclein-dependent mechanism. J. Pharmacol. Exp. Ther. 341, 484492.
  • Cheer J. F., Aragona B. J., Heien M. L., Seipel A. T., Carelli R. M. and Wightman R. M. (2007) Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 54, 237244.
  • Chen G. and Ewing A. G. (1995) Multiple classes of catecholamine vesicles observed during exocytosis from the Planorbis cell body. Brain Res. 701, 167174.
  • Daberkow D. P., Brown H. D., Bunner K. D., Kraniotis S. A., Doellman M. A., Ragozino M. E., Garris P. A. and Roitman M. F. (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J. Neurosci. 33, 452463.
  • Di C. G. and Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. U. S. A. 85, 52745278.
  • Everitt B. J. and Robbins T. W. (2005) Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 8, 14811489.
  • Ewing A. G., Bigelow J. C. and Wightman R. M. (1983) Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221, 169171.
  • Fleckenstein A. E., Haughey H. M., Metzger R. R., Kokoshka J. M., Riddle E. L., Hanson J. E., Gibb J. W. and Hanson G. R. (1999) Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur. J. Pharmacol. 382, 4549.
  • Fleckenstein A. E., Volz T. J., Riddle E. L., Gibb J. W. and Hanson G. R. (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681698.
  • Garris P. A. and Wightman R. M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14, 442450.
  • Garris P. A. and Wightman R. M. (1995) Distinct pharmacological regulation of evoked dopamine efflux in the amygdala and striatum of the rat in vivo. Synapse 20, 269279.
  • Garris P. A., Ciolkowski E. L. and Wightman R. M. (1994) Heterogeneity of evoked dopamine overflow within the striatal and striatoamygdaloid regions. Neuroscience 59, 417427.
  • Garris P. A., Christensen J. R., Rebec G. V. and Wightman R. M. (1997) Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J. Neurochem. 68, 152161.
  • Greengard P., Valtorta F., Czernik A. J. and Benfenati F. (1993) Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259, 780785.
  • Heal D. J., Cheetham S. C. and Smith S. L. (2009) The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 57, 608618.
  • Heien M. L., Phillips P. E., Stuber G. D., Seipel A. T. and Wightman R. M. (2003) Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst. 128, 14131419.
  • Hyman S. E. (2005) Addiction: a disease of learning and memory. Am. J. Psychiatry 162, 14141422.
  • Ingram S. L., Prasad B. M. and Amara S. G. (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat. Neurosci. 5, 971978.
  • Jones S. R., Garris P. A. and Wightman R. M. (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396403.
  • Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 19791986.
  • Kile B. M., Guillot T. S., Venton B. J., Wetsel W. C., Augustine G. J. and Wightman R. M. (2010) Synapsins differentially control dopamine and serotonin release. J. Neurosci. 30, 97629770.
  • Kuczenski R. (1975) Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase. Neuropharmacology 14, 110.
  • Kuczenski R. (1983) Biochemical actions of amphetamine and other stimulants, in Stimulants: Neurochemical, Behavioral and Clinical Perspectives (Creese I., ed.), pp. 3161. Raven Press, New York.
  • Kuczenski R. and Segal D. S. (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 10851094.
  • Kuhr W. G., Ewing A. G., Near J. A. and Wightman R. M. (1985) Amphetamine attenuates the stimulated release of dopamine in vivo. J. Pharmacol. Exp. Ther. 232, 388394.
  • Kuhr W. G., Bigelow J. C. and Wightman R. M. (1986) In vivo comparison of the regulation of releasable dopamine in the caudate nucleus and the nucleus accumbens of the rat brain. J. Neurosci. 6, 974982.
  • Lee T. H., Balu R., Davidson C. and Ellinwood E. H. (2001) Differential time-course profiles of dopamine release and uptake changes induced by three dopamine uptake inhibitors. Synapse 41, 301310.
  • Logman M. J., Budygin E. A., Gainetdinov R. R. and Wightman R. M. (2000) Quantitation of in vivo measurements with carbon fiber microelectrodes. J. Neurosci. Methods 95, 95102.
  • May L. J. and Wightman R. M. (1989) Heterogeneity of stimulated dopamine overflow within rat striatum as observed with in vivo voltammetry. Brain Res. 487, 311320.
  • May L. J., Kuhr W. G. and Wightman R. M. (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J. Neurochem. 51, 10601069.
  • Michael D., Travis E. R. and Wightman R. M. (1998) Color images for fast-scan CV measurements in biological systems. Anal. Chem. 70, 586A592A.
  • Mundorf M. L., Hochstetler S. E. and Wightman R. M. (1999) Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J. Neurochem. 73, 23972405.
  • Oleson E. B., Salek J., Bonin K. D., Jones S. R. and Budygin E. A. (2009) Real-time voltammetric detection of cocaine-induced dopamine changes in the striatum of freely moving mice. Neurosci. Lett. 467, 144146.
  • Patel J., Mooslehner K. A., Chan P. M., Emson P. C. and Stamford J. A. (2003) Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J. Neurochem. 85, 898910.
  • Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
  • Peacock J. and Benca R. M. (2010) Narcolepsy: clinical features, co-morbidities & treatment. Indian J. Med. Res. 131, 338349.
  • Pieribone V. A., Shupliakov O., Brodin L., Hilfiker-Rothenfluh S., Czernik A. J. and Greengard P. (1995) Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493497.
  • Ramsson E. S., Covey D. P., Daberkow D. P., Litherland M. T., Juliano S. A. and Garris P. A. (2011a) Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. J. Neurochem. 117, 937948.
  • Ramsson E. S., Howard C. D., Covey D. P. and Garris P. A. (2011b) High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J. Neurochem. 119, 11621172.
  • Riddle E. L., Topham M. K., Haycock J. W., Hanson G. R. and Fleckenstein A. E. (2002) Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine. Eur. J. Pharmacol. 449, 7174.
  • Riddle E. L., Hanson G. R. and Fleckenstein A. E. (2007) Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2. Eur. J. Pharmacol. 571, 2528.
  • Ritz M. C., Lamb R. J., Goldberg S. R. and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 12191223.
  • Rizzoli S. O. and Betz W. J. (2005) Synaptic vesicle pools. Nat. Rev. Neurosci. 6, 5769.
  • Robinson D. L. and Wightman R. M. (2004) Nomifensine amplifies subsecond dopamine signals in the ventral striatum of freely-moving rats. J. Neurochem. 90, 894903.
  • Robinson D. L. and Wightman R. M. (2007) Rapid dopamine release in freely moving rats, in Electrochemical Methods for Neuroscience (Michael A. C. and Borland L. M., eds), pp. 1734. CRC Press, Boca Raton.
  • Schmitz Y., Lee C. J., Schmauss C., Gonon F. and Sulzer D. (2001) Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores. J. Neurosci. 21, 59165924.
  • Scorza M. C., Carrau C., Silveira R., Zapata-Torres G., Cassels B. K. and Reyes-Parada M. (1997) Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure–activity relationships. Biochem. Pharmacol. 54, 13611369.
  • Seiden L. S., Sabol K. E. and Ricaurte G. A. (1993) Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639677.
  • Shore P. A. (1976) Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron. J. Pharm. Pharmacol. 28, 855857.
  • Stuber G. D., Wightman R. M. and Carelli R. M. (2005) Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron 46, 661669.
  • Sulzer D. (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628649.
  • Venton B. J., Seipel A. T., Phillips P. E., Wetsel W. C., Gitler D., Greengard P., Augustine G. J. and Wightman R. M. (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J. Neurosci. 26, 32063209.
  • Volz T. J., Farnsworth S. J., King J. L., Riddle E. L., Hanson G. R. and Fleckenstein A. E. (2007) Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J. Pharmacol. Exp. Ther. 323, 738745.
  • Volz T. J., Farnsworth S. J., Rowley S. D., Hanson G. R. and Fleckenstein A. E. (2008) Methylphenidate-induced increases in vesicular dopamine sequestration and dopamine release in the striatum: the role of muscarinic and dopamine D2 receptors. J. Pharmacol. Exp. Ther. 327, 161167.
  • Wanat M. J., Willuhn I., Clark J. J. and Phillips P. E. (2009) Phasic dopamine release in appetitive behaviors and drug addiction. Curr. Drug Abuse Rev. 2, 195213.
  • Wightman R. M., Amatore C., Engstrom R. C., Hale P. D., Kristensen E. W., Kuhr W. G. and May L. J. (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25, 513523.
  • Wu Q., Reith M. E., Kuhar M. J., Carroll F. I. and Garris P. A. (2001a) Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission. J. Neurosci. 21, 63386347.
  • Wu Q., Reith M. E., Wightman R. M., Kawagoe K. T. and Garris P. A. (2001b) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J. Neurosci. Methods 112, 119133.